PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11022896

Functional testing: ACEI renography.

A Taylor
View original source ↗Export metadata ↓

Abstract

Angiotensin-converting enzyme inhibition (ACEI) renography is the only imaging examination that tests directly for the presence of renovascular hypertension (RVH); other imaging examinations test only for the presence of renal artery stenosis (RAS). Consensus panels have recommended that ACEI renograms be interpreted as low, intermediate, or high probability for RVH. ACEI renography is highly accurate in patients with normal renal function and suspected RVH. In this patient population, the sensitivity and specificity of ACEI renography for RAS are approximately 90%; as an initial approach, angiography is not cost effective. Data from 10 studies evaluating cure or improvement in blood pressure in 291 patients undergoing revascularization showed the mean positive predictive value of ACEI renography to be 92%. When azotemic patients present with suspected RVH, as many as 50% of patients may have an intermediate probability ACEI renogram and the sensitivity of detecting RVH falls to approximately 80% even when intermediate and high probability tests are combined.

Explore related subjects

Angiotensin-Converting Enzyme InhibitorsCaptoprilCosts and Cost AnalysisEnalaprilatHumansHypertension, RenovascularRadioisotope RenographyRadiopharmaceuticalsRenal Artery ObstructionSensitivity and SpecificityJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Taylor. 2000. Functional testing: ACEI renography.. https://pubmed.ncbi.nlm.nih.gov/11022896/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Facile incorporation of urea pseudopeptides into protease substrate analogue inhibitors.

A new procedure that employs a one-pot, oxidative Hofmann rearrangement to incorporate a urea linkage into peptide backbones is detailed herein. This methodology was used to replace the scissile peptide bonds of [Leu5]enkephalin and a hexapeptide HIV-1 protease substrate. The [Leu5]enkephalin analogue was found to inhibit cleavage of hippurylhistidylleucine (HHL) by porcine kidney angiotensin-converting enzyme (PK-ACE) with a 0.88 mM IC50 value, comparable to the Michaelis constant of [Leu5]enkephalin with the same enzyme. The HIV-1 protease substrate analogue was shown to inhibit HIV-1 protease with an IC50=34 microM.

Angiotensin-Converting Enzyme Inhibitors↗
PubMed2004

3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.

Quadratic indices of the 'molecular pseudograph's atom adjacency matrix' have been generalized to codify chemical structure information for chiral drugs. These 3D-chiral quadratic indices make use of a trigonometric 3D-chirality correction factor. These indices are nonsymmetric and reduced to classical (2D) descriptors when symmetry is not codified. By this reason, it is expected that they will be useful to predict symmetry-dependent properties. 3D-Chirality quadratic indices are real numbers and thus, can be easily calculated in TOMOCOMD-CARDD software. These descriptors circumvent the inability of conventional 2D quadratic indices (Molecules 2003, 8, 687-726. http://www.mdpi.org) and other (chirality insensitive) topological indices to distinguish sigma-stereoisomers. In this paper, we extend our earlier work by applying 3D-chirality quadratic indices to two data sets containing chiral compounds. Consequently, in order to test the potential of this novel approach in drug design we have modelled the angiotesin-converting enzyme inhibitory activity of perindoprilate's sigma-stereoisomers combinatorial library. Two linear discriminant analysis (LDA) models were obtained. The first one model was performed considering all data set as training series and classifies correctly 88.89% of active compounds and 100.00% of nonactive one for a global good classification of 96.87%. The second one LDA-QSAR model classified correctly 83.33% of the active and 100.00% of the inactive compounds in a training set, result that represent a total of 95.65% accuracy in classification. On the other hand, the model classifies 100.00% of these compounds in the test set. Similar predictive behaviour was observed in a leave-one-out cross-validation procedure for both equations. Canonical regression analysis corroborated the statistical quality of these models (R(can) of 0.82 and of 0.76, respectively) and was also used to compute biology activity canonical scores for each compound. Finally, prediction of the biological activities of chiral 3-(3-hydroxyphenyl)piperidines, which are sigma-receptor antagonists, by linear multiple regression analysis was carried out. Two statistically significant QSAR models were obtained (R2=0.940, s=0.270 and R2=0.977, s=0.175). These models showed high stability to data variation in the leave-one-out cross-validation procedure (q2=0.912, scv=0.289 and q2=0.957, scv=0.211). The results of this study compare favourably with those obtained with other chirality descriptors applied to the same data set. The 3D-chiral TOMOCOMD-CARDD approach provides a powerful alternative to 3D-QSAR.

Angiotensin-Converting Enzyme Inhibitors↗
PubMed2004

Lisinopril quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry.

An analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection was developed for the determination of Lisinopril in human plasma using Enalaprilat as internal standard. The analyte and internal standard were extracted from the plasma samples by solid-phase extraction using Waters HLB Oasis SPE cartridges and chromatographed on a C8 analytical column. The mobile phase consisted of acetonitrile/water (60:40, v/v) + 20 mM acetic acid + 4.3 mM of triethylamine. The method had a chromatographic total run-time of 6.5 min and was linear within the range 2.00-200 ng/ml. Detection was carried out on a Micromass triple quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM). The precision (CV%) and accuracy, calculated from limit of quantification (LOQ) samples (n = 8), were 8.9 and 98.9%, respectively. The method herein described was employed in a bioequivalence study of two tablet formulations of Lisinopril 20mg.

Angiotensin-Converting Enzyme Inhibitors↗